多器官移植血管内大b细胞淋巴瘤的供体传播:捐献前供体疾病筛查中罕见缺陷的一例报告。

IF 0.8
Beatriz P Fernandes, Ana C Pimenta, Andreia Henriques, Clara Pardinhas, Rita Leal, Maria G Marques, Lídia Santos, Catarina Romãozinho, Vítor Sousa, Arnaldo Figueiredo, Rui Alves, Luís Rodrigues
{"title":"多器官移植血管内大b细胞淋巴瘤的供体传播:捐献前供体疾病筛查中罕见缺陷的一例报告。","authors":"Beatriz P Fernandes, Ana C Pimenta, Andreia Henriques, Clara Pardinhas, Rita Leal, Maria G Marques, Lídia Santos, Catarina Romãozinho, Vítor Sousa, Arnaldo Figueiredo, Rui Alves, Luís Rodrigues","doi":"10.1016/j.transproceed.2025.06.010","DOIUrl":null,"url":null,"abstract":"<p><p>The prevention of donor-transmitted diseases in solid organ transplantation depends on the thorough screening of donors while maintaining a high level of clinical suspicion. The evolution in these practices reduced the incidence of donor-transmitted tumors to minimal and unexpected events. Nevertheless, the recipients of these exceptional transmissions hold significant clinical consequences, challenging decisions, and poor outcomes. The intravascular large B-cell lymphoma (IVLBCL) is an extremely rare and aggressive tumor with almost exclusive intrasmall vessel growth. Its clinical and morphological features make diagnosing potential deceased donors virtually impossible. We report the case of the post-transplant diagnosis of the transmission of this cancer in a multiorgan kidney and liver transplantation. Following the IVLBCL diagnosis on a routine preimplantation kidney biopsy, the transplanted kidney grafts were removed, and a conservative management approach was adopted for the liver recipient. Histological examination of the kidney grafts revealed multifocal involvement by an IVLBCL neoplasm. Subsequent liver recipient biopsy showed no evidence of the known IVLBCL. After three years of follow-up, both kidney recipients have undergone a second kidney transplant, and the liver recipient continues to demonstrate no signs of the IVLBCL disease.</p>","PeriodicalId":94258,"journal":{"name":"Transplantation proceedings","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Donor Transmission of an Intravascular Large B-Cell Lymphoma in Multiorgan Transplantation: A Case Report From a Rare Pitfall in the Predonation Screening for Donor Disease.\",\"authors\":\"Beatriz P Fernandes, Ana C Pimenta, Andreia Henriques, Clara Pardinhas, Rita Leal, Maria G Marques, Lídia Santos, Catarina Romãozinho, Vítor Sousa, Arnaldo Figueiredo, Rui Alves, Luís Rodrigues\",\"doi\":\"10.1016/j.transproceed.2025.06.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The prevention of donor-transmitted diseases in solid organ transplantation depends on the thorough screening of donors while maintaining a high level of clinical suspicion. The evolution in these practices reduced the incidence of donor-transmitted tumors to minimal and unexpected events. Nevertheless, the recipients of these exceptional transmissions hold significant clinical consequences, challenging decisions, and poor outcomes. The intravascular large B-cell lymphoma (IVLBCL) is an extremely rare and aggressive tumor with almost exclusive intrasmall vessel growth. Its clinical and morphological features make diagnosing potential deceased donors virtually impossible. We report the case of the post-transplant diagnosis of the transmission of this cancer in a multiorgan kidney and liver transplantation. Following the IVLBCL diagnosis on a routine preimplantation kidney biopsy, the transplanted kidney grafts were removed, and a conservative management approach was adopted for the liver recipient. Histological examination of the kidney grafts revealed multifocal involvement by an IVLBCL neoplasm. Subsequent liver recipient biopsy showed no evidence of the known IVLBCL. After three years of follow-up, both kidney recipients have undergone a second kidney transplant, and the liver recipient continues to demonstrate no signs of the IVLBCL disease.</p>\",\"PeriodicalId\":94258,\"journal\":{\"name\":\"Transplantation proceedings\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation proceedings\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.transproceed.2025.06.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.transproceed.2025.06.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

实体器官移植中供体传播疾病的预防取决于对供体的彻底筛查,同时保持高度的临床怀疑。这些实践的发展将供体传播肿瘤的发生率降低到最小和意想不到的事件。然而,这些特殊传播的接受者具有显著的临床后果,具有挑战性的决定和不良的结果。血管内大b细胞淋巴瘤(IVLBCL)是一种非常罕见的侵袭性肿瘤,几乎只在小血管内生长。它的临床和形态学特征使得诊断潜在的已故捐赠者几乎不可能。我们报告的情况下,移植后诊断的传播这种癌症的多器官肾和肝移植。在常规植入前肾活检诊断为IVLBCL后,将移植的肾移植物切除,并对肝受体采取保守治疗方法。肾移植物的组织学检查显示一个IVLBCL肿瘤累及多灶性。随后的肝受体活检显示没有已知的IVLBCL的证据。经过三年的随访,两名肾脏受体都接受了第二次肾脏移植,肝脏受体仍然没有表现出IVLBCL疾病的迹象。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Donor Transmission of an Intravascular Large B-Cell Lymphoma in Multiorgan Transplantation: A Case Report From a Rare Pitfall in the Predonation Screening for Donor Disease.

The prevention of donor-transmitted diseases in solid organ transplantation depends on the thorough screening of donors while maintaining a high level of clinical suspicion. The evolution in these practices reduced the incidence of donor-transmitted tumors to minimal and unexpected events. Nevertheless, the recipients of these exceptional transmissions hold significant clinical consequences, challenging decisions, and poor outcomes. The intravascular large B-cell lymphoma (IVLBCL) is an extremely rare and aggressive tumor with almost exclusive intrasmall vessel growth. Its clinical and morphological features make diagnosing potential deceased donors virtually impossible. We report the case of the post-transplant diagnosis of the transmission of this cancer in a multiorgan kidney and liver transplantation. Following the IVLBCL diagnosis on a routine preimplantation kidney biopsy, the transplanted kidney grafts were removed, and a conservative management approach was adopted for the liver recipient. Histological examination of the kidney grafts revealed multifocal involvement by an IVLBCL neoplasm. Subsequent liver recipient biopsy showed no evidence of the known IVLBCL. After three years of follow-up, both kidney recipients have undergone a second kidney transplant, and the liver recipient continues to demonstrate no signs of the IVLBCL disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信